These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis. Nakahara H; Song J; Sugimoto M; Hagihara K; Kishimoto T; Yoshizaki K; Nishimoto N Arthritis Rheum; 2003 Jun; 48(6):1521-9. PubMed ID: 12794819 [TBL] [Abstract][Full Text] [Related]
7. The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis. Dayer JM Rheumatology (Oxford); 2003 May; 42 Suppl 2():ii3-10. PubMed ID: 12817089 [TBL] [Abstract][Full Text] [Related]
8. Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist. Butler DM; Maini RN; Feldmann M; Brennan FM Eur Cytokine Netw; 1995; 6(4):225-30. PubMed ID: 8789287 [TBL] [Abstract][Full Text] [Related]
9. Neutralizing IL-21 and IL-15 inhibits pro-inflammatory cytokine production in rheumatoid arthritis. Andersson AK; Feldmann M; Brennan FM Scand J Immunol; 2008 Jul; 68(1):103-11. PubMed ID: 18482208 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-1beta influences the effect of infliximab on temporomandibular joint pain in rheumatoid arthritis. Kopp S; Alstergren P; Ernestam S; Nordahl S; Bratt J Scand J Rheumatol; 2006; 35(3):182-8. PubMed ID: 16766364 [TBL] [Abstract][Full Text] [Related]
11. Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors, IL-1 beta, and IL-8--markers of remission in rheumatoid arthritis during treatment with methotrexate. Seitz M; Loetscher P; Dewald B; Towbin H; Rordorf C; Gallati H; Gerber NJ J Rheumatol; 1996 Sep; 23(9):1512-6. PubMed ID: 8877917 [TBL] [Abstract][Full Text] [Related]
12. The role of interleukin-1 in the pathogenesis of rheumatoid arthritis. Kay J; Calabrese L Rheumatology (Oxford); 2004 Jun; 43 Suppl 3():iii2-iii9. PubMed ID: 15150426 [TBL] [Abstract][Full Text] [Related]
14. A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis. Hitchon CA; Alex P; Erdile LB; Frank MB; Dozmorov I; Tang Y; Wong K; Centola M; El-Gabalawy HS J Rheumatol; 2004 Dec; 31(12):2336-46. PubMed ID: 15570632 [TBL] [Abstract][Full Text] [Related]
15. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis. Paleolog EM; Young S; Stark AC; McCloskey RV; Feldmann M; Maini RN Arthritis Rheum; 1998 Jul; 41(7):1258-65. PubMed ID: 9663484 [TBL] [Abstract][Full Text] [Related]
16. Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor. Ernestam S; af Klint E; Catrina AI; Sundberg E; Engström M; Klareskog L; Ulfgren AK Arthritis Res Ther; 2006; 8(1):R18. PubMed ID: 16507118 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 subfamily cytokines and rheumatoid arthritis: role of antagonists. Jazayeri JA; Carroll GJ; Vernallis AB Int Immunopharmacol; 2010 Jan; 10(1):1-8. PubMed ID: 19804846 [TBL] [Abstract][Full Text] [Related]
18. Future trends in the treatment of rheumatoid arthritis: cytokine targets. Breedveld FC Rheumatology (Oxford); 1999 Nov; 38 Suppl 2():11-3. PubMed ID: 10646483 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of IL-15 in rheumatoid arthritis. Yang XK; Xu WD; Leng RX; Liang Y; Liu YY; Fang XY; Feng CC; Li R; Cen H; Pan HF; Ye DQ Hum Immunol; 2015 Nov; 76(11):812-8. PubMed ID: 26429323 [TBL] [Abstract][Full Text] [Related]
20. The role of interleukin-1 in bone resorption in rheumatoid arthritis. Strand V; Kavanaugh AF Rheumatology (Oxford); 2004 Jun; 43 Suppl 3():iii10-iii16. PubMed ID: 15150427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]